State & FederalMedicare AdvantageApril 30, 2022

New specialty pharmacy medical step therapy requirements

Beginning January 1, 2024, Empire became Anthem. This article, published under the former brand, now applies to Anthem.

Effective March 1, 2022, the following Part B medications from the current Clinical Utilization Management (UM) Guidelines will be included in our medical step therapy precertification review process. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below.

 

Clinical UM Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria.

 

Clinical UM Guidelines

Preferred drug(s)

Nonpreferred drug(s)

ING-CC-0062

Inflectra

Remicade, Infliximab (unbranded)

Avsola

Renflexis

 

EBSCARE-1124-22 March 2022

 

PUBLICATIONS: May 2022 Newsletter